乳腺癌中的内质网膜应激:预后和治疗选择预测模型
Bin Yang1,2, Shu Wang3, Yanfang Yang1,2
1Research Laboratory Center, Guizhou Provincial People's Hospital, Guiyang, Guizhou, China.
Frontiers in immunology
|March 5, 2024
概括
这项研究确定了八个关键的细胞内网膜压力 (ERS) 基因,以创建乳腺癌预后模型. 该模型预测患者的风险,指导个性化治疗,并揭示高风险乳腺癌的潜在药物标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 基因组学就是基因组学.
背景情况:
- 乳腺癌 (BC) 仍然是女性死亡的重要原因,需要改善预后模型以获得有效的治疗.
- 细胞内膜网膜压力 (ERS) 与癌症的发展和进展有关,使其成为BC预后评估的潜在关键因素.
研究的目的:
- 开发一种精确的乳腺癌预后模型,利用与内质网膜压力 (ERS) 相关的基因.
- 为高风险乳腺癌患者确定新的治疗目标和策略.
主要方法:
- 综合分析与ERS相关的基因表达,使用跨多种BC亚型的单细胞和批量测序数据.
- 使用LASSO回归和机器学习技术构建和验证预后模型,并与现有模型进行比较.
- 利用ROC,DCA和KM分析进行模型验证和预测准确性的评估.
主要成果:
- 开发了一个八基因的ERS模型,有效地将BC患者分为不同的风险组,具有显著的预后差异.
- 该模型在预测存活率方面表现出高精度,并揭示了风险组之间的独特免疫透模式和治疗响应性.
- 确定了六个可用药物的标,其中甲托雷克萨特和格姆西塔宾被验证为高风险BC治疗的潜在有效药物.
结论:
- 这项研究在分子和细胞水平上建立了ERS和BC预后之间的重要联系,推进了个性化治疗策略.
- 基于ERS模型的患者分层突出了免疫细胞透和药物反应的差异,为量身定制的干预提供了信息.
- 已确定的药物标和治疗剂为向治疗提供了新的途径,以改善高风险BC患者的治疗结果.
更多相关视频
08:48An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation
Published on: June 30, 2015
8.3K
10:12Author Spotlight: Exploring the Role of Unfolded Protein Response in HIV-1 Replication and Infectivity
Published on: June 14, 2024
2.0K
相关概念视频
Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
The Unfolded Protein Response
4.6K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
4.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
